Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetyl-L-Carnitine for Chemotherapy-Induced Peripheral Neuropathy
NCT01526564Phase 3Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Aug 2008
- Primary completion
- Apr 2011
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of acetyl-l-carnitine in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Lee's Pharmaceutical Holdings Limited. Started Aug 2008; status: completed.
02
Drugs
acetyl-l-carnitine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT01526564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01526564.